ε-Amino-n-Caproic Acid is a lysine analog that inhibits carboxypeptidase B.
- Plasmin inhibitor
- Inhibits carboxypeptidase B
- Promotes rapid dissociation of plasmin by inhibiting activation of plasminogen
- Utilized in the clotting buffer for fibrinogen assays
EACA is reported to inhibit chymotrypsin, Factor VIIa, lysine carboxypeptidase, plasmin, and plasminogen activator. Lysine analog. Promotes rapid dissociation of plasmin, thereby inhibiting the activation of plasminogen and subsequent fibrinolysis. Reported to inhibit plasminogen binding to activated platelets. An early report indicated that it inhibits the activation of the first component of the complement system. Binds and inactivates Carboxypeptidase B.
Key Applications: Plasmin inhibitor, carboxypeptidase B inhibitor
Application Areas: Plasmin inhibitor, carboxypeptidase B inhibitor
Product Type: Biochemicals
Density: 1.48 g/mL (lit.)
Melting Point: 205 - 215°C
Presentation: White Powder
Format: Powder
Solubility: Soluble in water (50 mg/mL); sparingly soluble in alcohol and methanol; practically insoluble in ether; insoluble in ethanol.
Storage & Handling: Store at Room Temperature (15-30°C).